|
End-of-day quote
Nasdaq Riga
|
||
| - LVL | - |
|
| 07/01/22 | Delisting of AS "Olainfarm” shares from the Baltic Main list | AQ |
| 06/01/22 | Notification about results of final buy-back of shares | AQ |
| 30/12/21 | Notification about final share buy-back | AQ |
| 28/12/21 | Correction: Regarding results of a share buy-back offer | AQ |
| 28/12/21 | On substantial participation (4) - specified | AQ |
| Manager | Title | Age | Since |
|---|---|---|---|
Juris Hmelnickis
CEO | Chief Executive Officer | 46 | 01/01/2026 |
Janis Leimanis
DFI | Director of Finance/CFO | 56 | - |
| Chief Tech/Sci/R&D Officer | - | 01/01/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 19/06/2021 | |
Janis Buks
CHM | Chairman | - | 01/09/2022 |
Roberts Tavjevs
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | -1.45% | +16.59% | +67.77% | 47.69B | |
| -2.22% | +2.41% | +53.92% | +128.06% | 39.96B | |
| +1.13% | -1.43% | -6.99% | +16.31% | 12.02B | |
| +0.29% | -5.11% | +12.65% | +70.98% | 11.53B | |
| 0.00% | 0.00% | +30.00% | +147.62% | 9.18B | |
| -0.39% | +0.62% | +19.93% | +39.54% | 7.53B | |
| -1.51% | +0.58% | +46.79% | -12.07% | 7.29B | |
| +3.85% | +0.56% | +21.25% | +204.48% | 6.63B | |
| +2.65% | -3.55% | -31.27% | +24.03% | 5.57B | |
| Average | +0.45% | -1.92% | +18.10% | +76.30% | 16.38B | |
| Weighted average by Cap. | -0.24% | -2.14% | +25.38% | +84.25% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- OLF1R Stock
- OLF1R Stock
Select your edition
All financial news and data tailored to specific country editions
